AMI-4EUROPE

Advanced, Cross-Disciplinary & Integrated Medical Imaging for all EUropeans through a Network of Regional Clusters and DevelOPment StratEgies

FP7-REGIONS-2010-1

AMI-4EUROPE:

at a glance

(1)

Next Generation of Medical Imaging is just here out of the integration and crossdisciplinary use of NanoMedicine, Pharmacological breakthroughs, Biotechnologies for healthcare and ICT combined with standard Medical Imaging evolution. Healthcare sector is quite diverse and collaboration has been difficult as a result, so the challenge is to build expertise in the development of integrated systems that address unmet clinical needs while providing a solid and consistent network of R&D + Innovation groups.
FP7-REGIONS-2010-1

AMI-4EUROPE:

at a glance

(1)

AMI-4EUROPE is to co-ordinate, integrate and set up a newly defined EU-based Value Chain on Advanced, Cross-disciplinary and Integrated Medical Imaging by taking full advantage of all strengths that European stakeholders have while targeting the market niches that are arising as the Next Generation Medical Imaging unfolds itself

FP7-REGIONS-2010-1

AMI-4EUROPE:

MEDICAL IMAGING RESEARCH AGENDAS

Cross-Disciplinary Integrated Medical Imaging:

CLOUD MEDICAL IMAGING
NANOTECHNOLOGIES, BIOMATERIALS AND THE USE OF STEM CELLS AND TISSUE FOR CARDIOVASCULAR DIAGNOSIS & TREATMENT ICT & IMAGING FOR ONCOLOGICAL DIFFERENTIAL DIAGNOSIS NANOSCALE PHOTONIC IMAGING PRODUCTION OF NEW MOLECULES AND RESEARCH OF NEW MARKERS OF BIOLOGICAL PROCESSES
FP7-REGIONS-2010-1

AMI-4EUROPE:

KEY VALUE-ADDED ISSUES

Regions with former experience on economic development through health-related economy Strong technical expertise in the field Covering all major EU-27 areas + WBC + INCO Triple Helix in all regions + RDAs involved
FP7-REGIONS-2010-1

AMI-4EUROPE:

GEOGRAPHICAL COVERAGE

+ Africa and LatinAmerica

FP7-REGIONS-2010-1

AMI-4EUROPE:

MEDICAL IMAGING CURRENT EXPERTISE

Projects with socio-economic impact already started by partners:

CITE-C (Madrid) NANOCARDIO (Madrid)

USE OF STEM CELLS AND TISSUE FOR CARDIOVASCULAR DIAGNOSIS & TREATMENT (Hannover)
ICT & IMAGING FOR ONCOLOGICAL DIFFERENTIAL DIAGNOSIS (Hannover)

FP7-REGIONS-2010-1

AMI-4EUROPE:

IMPACT & EXIT STRATEGY (1)

An enabler for public (funding agencies) and private enterprises to enter (on a sound information basis) into the emerging field of Advanced Medical Imaging (AMI). Operationally geared to make Coordinating Action most valuable to the stakeholders in the field.

Business opportunities related to the wider field of economic growth in a global context. A business plan (WP 6) and private-public funding (WP 2) issues are part of the project activities.
A European and transnational level analysis will leverage the conclusions to the European level.
FP7-REGIONS-2010-1

AMI-4EUROPE:

IMPACT & EXIT STRATEGY (2)

A knowledge transfer from 5 regional RDC to two newly founded RDC (by coaching them and enabling ) is conceived, thus creating new business opportunities. Strong analysis of potential and anticipated impact in the fields of regional up to international business opportunities are considered. Impact on policy making (lead markets, Pro Inno initiative, EIT) is considered. The impact is aligned with the EU Commisions CIP programm and with the ETP Nanomedecine initiative.
FP7-REGIONS-2010-1

AMI-4EUROPE:

IMPACT & EXIT STRATEGY (3)

A Business Plan in support of JAP and the overall AMI strategy is to be defined, thus assuring maximum synergy searching and mid and long-term sustainability. To integrate and coordinate outcomes and results within the Europe INNOVA, PRO INNO Europe and the ETPs, to maximize synergies. AMI-TP Platform, AMI BackOffice, AMI DataWarehouse, AMI Advisory Council and European Cluster for AMI are to outlast the Project.

FP7-REGIONS-2010-1

AMI-4EUROPE:

NEGOTIATION PHASE (1)

Draft versions of DoW, budget breakdown, legal and financial data have been submitted and are in the process to be finalized. Budget adjustments have been made indications received in Negotiation Mandate: as per

60% flat rates down to 20% Detailed breakdowns by WP and activities provided Total requested funding reduced to the maximum amount indicated by the EC

Project is comprehensive, challenging and broader in scope. Thus, further budget reduction will result in loss of outcomes and results.
FP7-REGIONS-2010-1

AMI-4EUROPE:
OPEN ISSUES.

NEGOTIATION PHASE (2)

Treatment of organizations umbrella of the Clusters

participating

under

the

Beneficiaries vs. Third Parties vs. Consultants

Agreement on submitted budget and DoW Ways to proceed to clear pending legal issues with some beneficiaries Consortium Agreement Tentative starting date

ISSUES TO BE RAISED BY THE EC (if any).

FP7-REGIONS-2010-1